Alteration of DNA by 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (NSC-407347).
作者信息
Mizuno N S, Decker R W
出版信息
Biochem Pharmacol. 1976 Dec 1;25(23):2643-7. doi: 10.1016/0006-2952(76)90521-9.
PMID:985584
Abstract
摘要
相似文献
1
Alteration of DNA by 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (NSC-407347).
Biochem Pharmacol. 1976 Dec 1;25(23):2643-7. doi: 10.1016/0006-2952(76)90521-9.
2
Effects of 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (NSC-407347), an alkylating agent derived from 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).5-(3-甲基-1-三氮烯基)咪唑-4-甲酰胺（NSC-407347）的作用，它是一种由5-(3,3-二甲基-1-三氮烯基)咪唑-4-甲酰胺（NSC-45388）衍生而来的烷化剂。
Biochem Pharmacol. 1975 Mar 1;24(5):615-9. doi: 10.1016/0006-2952(75)90182-3.
3
Synthesis and antileukemic activities of furanyl, pyranyl, and ribosyl derivatives of 4-(3,3-dimethyl-1-triazeno)imidazole-5-carboxamide and 3-(3,3-dimethyl-1-triazeno)pyrazole-4-carboxamide.4-(3,3-二甲基-1-三氮烯基)咪唑-5-甲酰胺和3-(3,3-二甲基-1-三氮烯基)吡唑-4-甲酰胺的呋喃基、吡喃基和核糖基衍生物的合成及其抗白血病活性
J Med Chem. 1979 Nov;22(11):1422-5. doi: 10.1021/jm00197a028.
4
5
Effects of 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide [NSC 45388, DTIC] on neuroblastoma cells in culture.5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺[NSC 45388，达卡巴嗪]对培养的神经母细胞瘤细胞的作用。
Biochem Biophys Res Commun. 1977 Jun 6;76(3):778-83. doi: 10.1016/0006-291x(77)91568-6.
6
Mechanism of action of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide in mammalian cells in culture.5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺在培养的哺乳动物细胞中的作用机制
Biochem Pharmacol. 1972 Sep 1;21(17):2335-43. doi: 10.1016/0006-2952(72)90384-x.
7
8
5-(3-Hydroxymethyl-3-methyl-1-triazeno imidazole-4-carboxamide is a metabolite of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DIC, DTIC NSC-45388).5-（3-羟甲基-3-甲基-1-三氮烯基）咪唑-4-甲酰胺是5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺（DIC，DTIC NSC-45388）的一种代谢产物。
Cancer Lett. 1980 Sep;10(3):235-41. doi: 10.1016/0304-3835(80)90076-2.
9
Attempt to alter antigenic structure of normal tissues by treatment with dimethyl-triazeno-imidazole-carboxamide in vivo.尝试通过在体内用二甲基三氮烯咪唑甲酰胺处理来改变正常组织的抗原结构。
Experientia. 1976 Jun 15;32(6):741-2. doi: 10.1007/BF01919863.
10
Comparative study of methyl-CCNU (NSC-95441) with cyclophosphamide (NSC-26271) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) with vincristine (NSC-67574) in patients with disseminated malignant melanoma.甲环亚硝脲（NSC - 95441）与环磷酰胺（NSC - 26271）以及5 -（3,3 - 二甲基 - 1 - 三氮烯基）咪唑 - 4 - 甲酰胺（NSC - 45388）与长春新碱（NSC - 67574）治疗播散性恶性黑色素瘤患者的对比研究。
Cancer Chemother Rep. 1975 Mar-Apr;59(2 Pt 1):451-3.
引用本文的文献
1
Temozolomide and Other Alkylating Agents in Glioblastoma Therapy.替莫唑胺及其他烷化剂在胶质母细胞瘤治疗中的应用
Biomedicines. 2019 Sep 9;7(3):69. doi: 10.3390/biomedicines7030069.
2
Synthesis and Molecular-cellular Mechanistic Study of Pyridine Derivative of Dacarbazine.达卡巴嗪吡啶衍生物的合成及其分子细胞机制研究
Iran J Pharm Res. 2013 Summer;12(3):255-65.
3
N-methyl antitumour agents. A distinct class of anticancer drugs?N-甲基抗肿瘤药物。一类独特的抗癌药物？
Cancer Chemother Pharmacol. 1987;19(2):91-102. doi: 10.1007/BF00254559.
Zotero 插件